Valore202020212022202320242025TTMSpese di vendita, generali e amministrative11.62 B12.7 B13.68 B14.77 B14.73 B13.79 B13.72 BRicerca e sviluppo9.4 B13.83 B12.38 B10.87 B10.93 B12.05 B12.46 BReddito operativo9.65 B19.28 B34.45 B20.82 B8.51 B13.29 B6.9 BProventi non operativi, Totale440 M8.4 B1.85 B5.88 B-2.88 B-5.48 B-6.42 BOneri finanziari, al netto degli interessi capitalizzati1.45 B1.29 B1.24 B2.21 B3.09 B2.67 B2.69 BProventi non operativi, esclusi gli oneri finanziari-340 M2.23 B833 M2.84 B-1.58 B-1.43 B-2.47 BEntrate/uscite straordinarie-669 M4.88 B-217 M835 M-4.39 B-6.72 B-6.63 BUtile al lordo delle imposte7.5 B24.31 B34.73 B1.06 B8.02 B7.52 B7.91 BQuota di utile———————Imposte477 M1.85 B3.33 B-1.11 B-28 M-266 M384 MInteressi di minoranza36 M45 M35 M39 M31 M41 M43 MAltri proventi/oneri al netto delle imposte478 M1.57 B-758 M3.49 B2.26 B470 M603 MUtile netto al lordo delle attività cessate6.99 B22.41 B31.37 B2.13 B8.02 B7.75 B7.48 BAttività cessate2.63 B-434 M6 M-15 M11 M25 M12 MUtile netto9.62 B21.98 B31.37 B2.12 B8.03 B7.77 B7.49 BRegolazione della diluizione00—————Dividendi privilegiati00—————Utile netto diluito attribuibile agli azionisti ordinari9.62 B21.98 B31.37 B2.12 B8.03 B7.77 B7.49 BUtile base per azione (EPS base)1.733.925.590.381.421.371.32Utile diluito per azione (EPS diluito)1.713.855.470.371.411.361.31Numero medio di azioni ordinarie in circolazione5.55 B5.6 B5.61 B5.64 B5.66 B5.68 B—Azioni diluite in circolazione5.63 B5.71 B5.73 B5.71 B5.7 B5.71 B—EBITDA—24.84 B39.97 B27.11 B16.72 B19.88 B13.48 BEBIT9.65 B19.28 B34.45 B20.82 B8.51 B13.29 B6.9 BCosto del fatturato8.69 B30.82 B34.34 B24.95 B17.85 B16.07 B16.77 BAltri costi del venduto———6.2 B00—Ammortamento e svalutazione (liquidità)—5.19 B5.06 B6.29 B7.01 B6.59 B6.59 B
Pfizer, Inc. Common Stock
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.